- Home
- ELF vs LEGN Comparison
ELF vs LEGN Comparison
Compare ELF & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELF | LEGN |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | United States | United States |
| Employees | 849 | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.9B |
| IPO Year | 2016 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ELF | LEGN |
|---|---|---|
| Price | $96.45 | $17.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 12 |
| Target Price | ★ $111.88 | $61.33 |
| AVG Volume (30 Days) | 1.4M | ★ 1.6M |
| Earning Date | 05-27-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.12 | N/A |
| Revenue | ★ $1,636,472,000.00 | N/A |
| Revenue This Year | $23.87 | $42.68 |
| Revenue Next Year | $17.15 | $30.52 |
| P/E Ratio | $83.32 | ★ N/A |
| Revenue Growth | ★ 24.59 | N/A |
| 52 Week Low | $48.82 | $16.24 |
| 52 Week High | $147.75 | $37.50 |
Technical Indicators
Market Signals| Indicator | ELF | LEGN |
|---|---|---|
| Relative Strength Index (RSI) | 48.46 | 34.17 |
| Support Level | $89.38 | $16.47 |
| Resistance Level | $97.10 | $21.99 |
| Average True Range (ATR) | 4.47 | 0.91 |
| MACD | -1.98 | -0.27 |
| Stochastic Oscillator | 26.66 | 14.64 |
Price Performance
Historical ComparisonAbout ELF e.l.f. Beauty Inc.
e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan, and cruelty-free cosmetics and skin care products. The Company's mission is to make beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women, which include eyeliner, mascara, false eyelashes, lipstick, foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.